scPharmaceuticals Inc (SCPH)
4.55
+0.09
(+2.02%)
USD |
NASDAQ |
May 01, 16:00
4.55
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Price to Book Value: 4.408 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 4.321 |
| April 29, 2024 | 4.437 |
| April 26, 2024 | 4.350 |
| April 25, 2024 | 4.214 |
| April 24, 2024 | 4.359 |
| April 23, 2024 | 4.466 |
| April 22, 2024 | 4.427 |
| April 19, 2024 | 4.417 |
| April 18, 2024 | 4.369 |
| April 17, 2024 | 4.282 |
| April 16, 2024 | 4.524 |
| April 15, 2024 | 4.708 |
| April 12, 2024 | 4.776 |
| April 11, 2024 | 4.941 |
| April 10, 2024 | 4.631 |
| April 09, 2024 | 4.863 |
| April 08, 2024 | 4.776 |
| April 05, 2024 | 4.873 |
| April 04, 2024 | 4.979 |
| April 03, 2024 | 5.047 |
| April 02, 2024 | 4.631 |
| April 01, 2024 | 4.698 |
| March 28, 2024 | 4.863 |
| March 27, 2024 | 4.873 |
| March 26, 2024 | 4.756 |
| Date | Value |
|---|---|
| March 25, 2024 | 4.708 |
| March 22, 2024 | 5.008 |
| March 21, 2024 | 5.212 |
| March 20, 2024 | 5.406 |
| March 19, 2024 | 5.202 |
| March 18, 2024 | 5.318 |
| March 15, 2024 | 5.648 |
| March 14, 2024 | 5.134 |
| March 13, 2024 | 5.270 |
| March 12, 2024 | 5.192 |
| March 11, 2024 | 5.115 |
| March 08, 2024 | 5.212 |
| March 07, 2024 | 5.493 |
| March 06, 2024 | 5.716 |
| March 05, 2024 | 5.677 |
| March 04, 2024 | 5.812 |
| March 01, 2024 | 5.929 |
| February 29, 2024 | 5.832 |
| February 28, 2024 | 5.818 |
| February 27, 2024 | 6.011 |
| February 26, 2024 | 5.789 |
| February 23, 2024 | 5.47 |
| February 22, 2024 | 5.451 |
| February 21, 2024 | 5.393 |
| February 20, 2024 | 5.509 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7733
Minimum
Jun 24 2019
8.243
Maximum
Nov 25 2022
3.140
Average
2.698
Median
Sep 24 2021
Price to Book Value Benchmarks
| Anika Therapeutics Inc | 1.849 |
| Spero Therapeutics Inc | 0.7814 |
| electroCore Inc | 5.033 |
| NovaBay Pharmaceuticals Inc | 1.968 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 12.89 |
| Price | 4.55 |
| Earnings Yield | -31.21% |
| Market Cap | 164.05M |